Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055182

President & CEO gave up 852 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-14 Shares withheld for taxes : show line 1 in the form −852 $92.69 $78,972 610,189 D
Loading xslF345X03/doc4.xml…